Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CPIC is a Community Partnered Participatory Research (CPPR) Project of Community and Academic Partners Working Together to Learn the Best Way to Reduce Depression in Our Communities.
Brief Summary: CPIC is a community initiative and research study funded by the NIH. CPIC was developed and is being run by community and academic partners in Los Angeles underserved communities of color. CPIC compares two ways of supporting diverse health and social programs in under-resourced communities to improve their services to depressed clients. One approach is time-limited expert technical assistance coupled with culturally-competent community outreach to individual programs, on how to use quality improvement toolkits for depression that have already been proven to be effective or helpful in primary care settings, but adapted for this study for use in diverse community-based programs in underserved communities. The other approach brings different types of agencies and members in a community together in a 4 to 6-month planning process, to fit the same depression quality improvement programs to the needs and strengths of the community and to develop a network of programs serving the community to support clients with depression together. The study is designed to determine the added value of community engagement and planning over and above what might be offered through a community-oriented, disease management company. Both intervention models are based on the same quality improvement toolkits that support team leadership, care management, Cognitive Behavioral Therapy, medication management, and patient education and activation. Investigators hypothesized that the community engagement approach would increase agency and clinician participation in evidence-based trainings and improve client mental health-related quality of life. In addition, during the design phase, community participants prioritized adding as outcomes indicators of social determinants of mental health, including physical functioning, risk factors for homelessness and employment. Investigators hypothesized by activating community agencies that can address health and social services needs to engage depressed clients, these outcomes would also be improved more in the collaboration condition. Investigators also hypothesized that the collaboration approach would increase use of services.


Options:
A: Arm Label: Resources for Services; Type: ACTIVE_COMPARATOR; Interventions: Other: Quality Improvement Program, Behavioral: Resources for Services Expert Team | Arm Label: Community Engagement and Planning; Type: EXPERIMENTAL; Interventions: Other: Quality Improvement Program, Behavioral: Community Engagement and Planning Council | Intervention Type: OTHER; Name: Quality Improvement Program; Assigned to Arm(s): Community Engagement and Planning, Resources for Services | Intervention Type: BEHAVIORAL; Name: Resources for Services Expert Team; Assigned to Arm(s): Resources for Services | Intervention Type: BEHAVIORAL; Name: Community Engagement and Planning Council; Assigned to Arm(s): Community Engagement and Planning
B: Arm Label: Integrated family-focused PMTCT arm; Type: EXPERIMENTAL; Interventions: Other: Task-shifting to lower-cadre providers at PMTCT sites, Other: POC CD4+ cell count testing, Other: integrated mother-infant care, Other: Prominent role for influential family members (male partners) in collaboration with CHWs | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Task-shifting to lower-cadre providers at PMTCT sites; Assigned to Arm(s): Integrated family-focused PMTCT arm | Intervention Type: OTHER; Name: POC CD4+ cell count testing; Assigned to Arm(s): Integrated family-focused PMTCT arm | Intervention Type: OTHER; Name: integrated mother-infant care; Assigned to Arm(s): Integrated family-focused PMTCT arm | Intervention Type: OTHER; Name: Prominent role for influential family members (male partners) in collaboration with CHWs; Assigned to Arm(s): Integrated family-focused PMTCT arm
C: Arm Label: GSK257049 [5-17M] Group; Type: EXPERIMENTAL; Interventions: Biological: Malaria Vaccine 257049, Biological: Meningococcal C Conjugate Vaccine | Arm Label: GSK257049 [6-12W] Group; Type: EXPERIMENTAL; Interventions: Biological: Malaria Vaccine 257049, Biological: Meningococcal C Conjugate Vaccine, Biological: TritanrixHepB/Hib, Biological: Polio Sabin Oral Polio Vaccine (GSK) | Arm Label: VeroRab Comparator [5-17M] Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Meningococcal C Conjugate Vaccine, Biological: Cell-culture rabies vaccine | Arm Label: Menjugate Comparator [6-12W] Group; Type: EXPERIMENTAL; Interventions: Biological: Meningococcal C Conjugate Vaccine, Biological: TritanrixHepB/Hib, Biological: Polio Sabin Oral Polio Vaccine (GSK) | Intervention Type: BIOLOGICAL; Name: Malaria Vaccine 257049; Assigned to Arm(s): GSK257049 [5-17M] Group, GSK257049 [6-12W] Group | Intervention Type: BIOLOGICAL; Name: Meningococcal C Conjugate Vaccine; Assigned to Arm(s): GSK257049 [5-17M] Group, GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group, VeroRab Comparator [5-17M] Group | Intervention Type: BIOLOGICAL; Name: Cell-culture rabies vaccine; Assigned to Arm(s): VeroRab Comparator [5-17M] Group | Intervention Type: BIOLOGICAL; Name: TritanrixHepB/Hib; Assigned to Arm(s): GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group | Intervention Type: BIOLOGICAL; Name: Polio Sabin Oral Polio Vaccine (GSK); Assigned to Arm(s): GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group
D: Arm Label: All Nations Breath of Life (ANBL); Type: EXPERIMENTAL; Interventions: Behavioral: All Nations Breath of Life (ANBL), Drug: Pharmacotherapy | Arm Label: Nontailored (NT); Type: EXPERIMENTAL; Interventions: Behavioral: Nontailored program (NT), Drug: Pharmacotherapy | Intervention Type: BEHAVIORAL; Name: All Nations Breath of Life (ANBL); Assigned to Arm(s): All Nations Breath of Life (ANBL) | Intervention Type: BEHAVIORAL; Name: Nontailored program (NT); Assigned to Arm(s): Nontailored (NT) | Intervention Type: DRUG; Name: Pharmacotherapy; Assigned to Arm(s): All Nations Breath of Life (ANBL), Nontailored (NT)

Answer: A